Hong Kong’s ban on cannabidiol (CBD) comes into effect on February 1, imposing harsh penalties for importing, producing, or possessing the substance.
CBD will be subject to the same strict controls as other drugs listed under the Dangerous Drugs Ordinance (DDO).
The importation of goods containing the component, including food and beverages, is forbidden, according to Hong Kong's customs administration, unless pertinent DDO rules are followed.
Au-Yeung Ka-lun, a customs intelligence officer, stated that CBD will be treated as a dangerous narcotic and will be governed by the Dangerous Drugs Ordinance.
The maximum punishment for importing, exporting, and producing CBD is a HKD 5 million fine and a life sentence. The maximum penalty for possession is seven years in prison and a fine of up to HKD 1 million.
By the end of the month, all items containing the component were to be put in trash boxes erected throughout the city, according to a government directive. Approximately 77,400 CBD-containing products, including dietary supplements and edible oils, have been gathered as of January 29.


Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion
Wall Street Slides as Iran War Uncertainty, Oil Surge, and AI Fears Rattle Markets
WTO Reform Talks Begin in Cameroon Amid Global Trade Tensions
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025
xAI Faces Lawsuit Over Grok AI-Generated Sexual Content Involving Minors
Anthropic Sues Pentagon Over AI Blacklist, Citing Free Speech Violations
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
Estée Lauder Sues Jo Malone Over Trademark Dispute Involving Zara
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
U.S. Appeals Court Strikes Down FTC Order Against TurboTax "Free" Advertising
Sonova Shares Slip as Hearing Aid Giant Lowers Growth Outlook and Plans Sennheiser Exit 



